肥胖与体脂分布对冠心病、卒中亚型及2型糖尿病的因果关联:孟德尔随机化分析
结果示两者均因果影响冠心病和2型糖尿病,中心性肥胖可能对卒中风险影响更强。
要点
- WHRadjBMI每升高1 SD,冠心病风险OR 1.48(95%CI 1.28-1.71),BMI每升高1 SD,OR 1.36(95%CI 1.22-1.52)。
- 仅WHRadjBMI升高与缺血性卒中风险增加相关(OR 1.32,95%CI 1.03-1.70)。
- WHRadjBMI和BMI每升高1 SD,2型糖尿病风险分别OR 1.82(95%CI 1.38-2.42)和OR 1.98(95%CI 1.41-2.78)。
核心结论
- 一般性和中心性肥胖均对冠心病和2型糖尿病有因果效应,中心性肥胖可能对卒中风险影响更强。
主要发现
- WHRadjBMI每升高1 SD(约0.08 U),冠心病风险OR 1.48(95%CI 1.28-1.71);BMI每升高1 SD(约4.6 kg/m2),OR 1.36(95%CI 1.22-1.52)。
- 仅WHRadjBMI升高与缺血性卒中风险增加相关(OR 1.32,95%CI 1.03-1.70)。
- WHRadjBMI和BMI每升高1 SD,2型糖尿病风险分别OR 1.82(95%CI 1.38-2.42)和OR 1.98(95%CI 1.41-2.78)。
- WHRadjBMI和BMI均与左心室肥厚、血糖特征、白细胞介素6和循环血脂升高相关。
- WHRadjBMI每升高1 SD,颈动脉内膜中层厚度增加39%(95%CI 9%-77%)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The implications of different adiposity measures on cardiovascular disease etiology remain unclear. In this article, we quantify and contrast causal associations of central adiposity (waist-to-hip ratio adjusted for body mass index [WHRadjBMI]) and general adiposity (body mass index [BMI]) with cardiometabolic disease. METHODS: Ninety-seven independent single-nucleotide polymorphisms for BMI and 49 single-nucleotide polymorphisms for WHRadjBMI were used to conduct Mendelian randomization analyses in 14 prospective studies supplemented with coronary heart disease (CHD) data from CARDIoGRAMplusC4D (Coronary Artery Disease Genome-wide Replication and Meta-analysis [CARDIoGRAM] plus The Coronary Artery Disease [C4D] Genetics; combined total 66 842 cases), stroke from METASTROKE (12 389 ischemic stroke cases), type 2 diabetes mellitus from DIAGRAM (Diabetes Genetics Replication and Meta-analysis; 34 840 cases), and lipids from GLGC (Global Lipids Genetic Consortium; 213 500 participants) consortia. Primary outcomes were CHD, type 2 diabetes mellitus, and major stroke subtypes; secondary analyses included 18 cardiometabolic traits. RESULTS: Each one standard deviation (SD) higher WHRadjBMI (1 SD≈0.08 U) associated with a 48% excess risk of CHD (odds ratio [OR] for CHD, 1.48; 95% confidence interval [CI], 1.28-1.71), similar to findings for BMI (1 SD≈4.6 kg/m2; OR for CHD, 1.36; 95% CI, 1.22-1.52). Only WHRadjBMI increased risk of ischemic stroke (OR, 1.32; 95% CI, 1.03-1.70). For type 2 diabetes mellitus, both measures had large effects: OR, 1.82 (95% CI, 1.38-2.42) and OR, 1.98 (95% CI, 1.41-2.78) per 1 SD higher WHRadjBMI and BMI, respectively. Both WHRadjBMI and BMI were associated with higher left ventricular hypertrophy, glycemic traits, interleukin 6, and circulating lipids. WHRadjBMI was also associated with higher carotid intima-media thickness (39%; 95% CI, 9%-77% per 1 SD). CONCLUSIONS: Both general and central adiposity have causal effects on CHD and type 2 diabetes mellitus. Central adiposity may have a stronger effect on stroke risk. Future estimates of the burden of adiposity on health should include measures of central and general adiposity.
引用
- Dale CE, Fatemifar G, Palmer TM, et al. Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis. Circulation. 2017. PMID: 28500271. doi:10.1161/CIRCULATIONAHA.116.026560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。